666 related articles for article (PubMed ID: 11940574)
1. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.
Leung JY; Kolligs FT; Wu R; Zhai Y; Kuick R; Hanash S; Cho KR; Fearon ER
J Biol Chem; 2002 Jun; 277(24):21657-65. PubMed ID: 11940574
[TBL] [Abstract][Full Text] [Related]
2. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.
Jho EH; Zhang T; Domon C; Joo CK; Freund JN; Costantini F
Mol Cell Biol; 2002 Feb; 22(4):1172-83. PubMed ID: 11809808
[TBL] [Abstract][Full Text] [Related]
3. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade.
Golan T; Yaniv A; Bafico A; Liu G; Gazit A
J Biol Chem; 2004 Apr; 279(15):14879-88. PubMed ID: 14747478
[TBL] [Abstract][Full Text] [Related]
4. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells.
Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK
Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388
[TBL] [Abstract][Full Text] [Related]
5. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.
Kolligs FT; Nieman MT; Winer I; Hu G; Van Mater D; Feng Y; Smith IM; Wu R; Zhai Y; Cho KR; Fearon ER
Cancer Cell; 2002 Mar; 1(2):145-55. PubMed ID: 12086873
[TBL] [Abstract][Full Text] [Related]
6. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway.
Furuhashi M; Yagi K; Yamamoto H; Furukawa Y; Shimada S; Nakamura Y; Kikuchi A; Miyazono K; Kato M
Mol Cell Biol; 2001 Aug; 21(15):5132-41. PubMed ID: 11438668
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas.
Koch A; Hrychyk A; Hartmann W; Waha A; Mikeska T; Waha A; Schüller U; Sörensen N; Berthold F; Goodyer CG; Wiestler OD; Birchmeier W; Behrens J; Pietsch T
Int J Cancer; 2007 Jul; 121(2):284-91. PubMed ID: 17373666
[TBL] [Abstract][Full Text] [Related]
9. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors.
Lustig B; Jerchow B; Sachs M; Weiler S; Pietsch T; Karsten U; van de Wetering M; Clevers H; Schlag PM; Birchmeier W; Behrens J
Mol Cell Biol; 2002 Feb; 22(4):1184-93. PubMed ID: 11809809
[TBL] [Abstract][Full Text] [Related]
10. The ankyrin repeat protein Diversin recruits Casein kinase Iepsilon to the beta-catenin degradation complex and acts in both canonical Wnt and Wnt/JNK signaling.
Schwarz-Romond T; Asbrand C; Bakkers J; Kühl M; Schaeffer HJ; Huelsken J; Behrens J; Hammerschmidt M; Birchmeier W
Genes Dev; 2002 Aug; 16(16):2073-84. PubMed ID: 12183362
[TBL] [Abstract][Full Text] [Related]
11. HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells.
Valenta T; Lukas J; Korinek V
Nucleic Acids Res; 2003 May; 31(9):2369-80. PubMed ID: 12711682
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells.
Helmbrecht K; Kispert A; von Wasielewski R; Brabant G
Endocrinology; 2001 Dec; 142(12):5261-6. PubMed ID: 11713224
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
14. The Axin-like protein PRY-1 is a negative regulator of a canonical Wnt pathway in C. elegans.
Korswagen HC; Coudreuse DY; Betist MC; van de Water S; Zivkovic D; Clevers HC
Genes Dev; 2002 May; 16(10):1291-302. PubMed ID: 12023307
[TBL] [Abstract][Full Text] [Related]
15. Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway.
Xiao JH; Ghosn C; Hinchman C; Forbes C; Wang J; Snider N; Cordrey A; Zhao Y; Chandraratna RA
J Biol Chem; 2003 Aug; 278(32):29954-62. PubMed ID: 12771132
[TBL] [Abstract][Full Text] [Related]
16. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
[TBL] [Abstract][Full Text] [Related]
17. Presenilin 1 regulates beta-catenin-mediated transcription in a glycogen synthase kinase-3-independent fashion.
Palacino JJ; Murphy MP; Murayama O; Iwasaki K; Fujiwara M; Takashima A; Golde TE; Wolozin B
J Biol Chem; 2001 Oct; 276(42):38563-9. PubMed ID: 11504726
[TBL] [Abstract][Full Text] [Related]
18. I-mfa domain proteins interact with Axin and affect its regulation of the Wnt and c-Jun N-terminal kinase signaling pathways.
Kusano S; Raab-Traub N
Mol Cell Biol; 2002 Sep; 22(18):6393-405. PubMed ID: 12192039
[TBL] [Abstract][Full Text] [Related]
19. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
20. A yeast model system for functional analysis of beta-catenin signaling.
Lee MS; D'Amour KA; Papkoff J
J Cell Biol; 2002 Sep; 158(6):1067-78. PubMed ID: 12235124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
